Last10K.com

Sio Gene Therapies Inc. (SIOX) SEC Filing 8-K Material Event for the period ending Wednesday, February 9, 2022

Sio Gene Therapies Inc.

HISTORY TOOLS
CIK: 1636050 Ticker: SIOX

View differences made from one to another to evaluate Sio Gene Therapies Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sio Gene Therapies Inc..

Continue

Assess how Sio Gene Therapies Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sio Gene Therapies Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover Page

Material Contracts, Statements, Certifications & more

Sio Gene Therapies Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: SIOX
CIK: 1636050
Form Type: 8-K Corporate News
Accession Number: 0001636050-22-000015
Submitted to the SEC: Wed Feb 09 2022 7:00:19 AM EST
Accepted by the SEC: Wed Feb 09 2022
Period: Wednesday, February 9, 2022
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Regulated Disclosure

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/siox/0001636050-22-000015.htm